| Ms Caroline Richelle Parker, MS, CCC-SLP | |
|
315 6th St S, Oneonta, AL 35121-1828 | |
| (205) 274-2244 | |
| Not Available |
| Full Name | Ms Caroline Richelle Parker |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 315 6th St S, Oneonta, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174273858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5126 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Caroline Richelle Parker, MS, CCC-SLP 329 Grove St, Springville, AL 35146-3531 Ph: (205) 915-3416 | Ms Caroline Richelle Parker, MS, CCC-SLP 315 6th St S, Oneonta, AL 35121-1828 Ph: (205) 274-2244 |
News Archive
Wandering, one of most dangerous side effects of Alzheimer's disease, recently took the life of a 66-year-old woman who was found frozen to death near her Scarborough home.
Researchers have developed a simple clinical decision rule that may help doctors identify patients with headache in the emergency department who have subarachnoid hemorrhage (bleeding in a certain area of the brain), according to a study in the September 25 issue of JAMA.
The H7N9 avian flu strain that emerged in China earlier this year has subsided for now, but it would be a mistake to be reassured by this apparent lull in infections. The virus has several highly unusual traits that paint a disquieting picture of a pathogen that may yet lead to a pandemic, according to lead scientists from the National Institute of Allergy and Infectious Diseases.
One approach being discussed would lower federal payments to states for Medicaid and the CHIP program — which as analysis says would lead to even more budget burdens for already cash-strapped states.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
› Verified 5 days ago
Kaleigh Hyatt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Joshua Kendal Hubbard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 212 Ellen St, Oneonta, AL 35121 Phone: 205-625-3520 | |
Mrs. Leah Shae Ganus, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-478-2244 | |
Phyllis Shirley, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Elinor Clay Anthony, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 | |
Abbey Oliver, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 6th St S, Oneonta, AL 35121 Phone: 205-274-2244 |